Chuah SK - Search Results

1

Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Helicobacter pylori Infection.

Chen CL, Wu IT, Wu DC, Lei WY, Tsay FW, Chuah SK, Chen KY, Yang JC, Liu YH, Kuo CH, Shiu SI, Shie CB, Lin KH, Lee CL, Hsu PI. Chen CL, et al. Among authors: chuah sk. Microorganisms. 2023 Dec 19;12(1):6. doi: 10.3390/microorganisms12010006. Microorganisms. 2023. PMID: 38276175 Free PMC article.

2

Association of the myeloperoxidase -468G-->A polymorphism with gastric inflammation and duodenal ulcer risk.

Hsu PI, Jwo JJ, Tseng HH, Lai KH, Lo GH, Lo CC, Wu CJ, Chuah SK, Hwang IR, Chen JL, Chen YS, Chen A. Hsu PI, et al. Among authors: chuah sk. World J Gastroenterol. 2005 May 14;11(18):2796-801. doi: 10.3748/wjg.v11.i18.2796. World J Gastroenterol. 2005. PMID: 15884126 Free PMC article.

3

Association of the myeloperoxidase polymorphism with the risk of gastric cancer.

Hsu PI, Jwo JJ, Yang CL, Hsu PN, Yang HB, Lai KH, Chen IS, Chuah SK, Wu DC, Chen A. Hsu PI, et al. Among authors: chuah sk. Anticancer Res. 2008 Mar-Apr;28(2B):1317-23. Anticancer Res. 2008. PMID: 18505072 Free article.

4

Clinical remission in endoscope-guided pneumatic dilation for the treatment of esophageal achalasia: 7-year follow-up results of a prospective investigation.

Chuah SK, Hu TH, Wu KL, Hsu PI, Tai WC, Chiu YC, Lee CM, Changchien CS. Chuah SK, et al. J Gastrointest Surg. 2009 May;13(5):862-7. doi: 10.1007/s11605-009-0804-z. Epub 2009 Jan 23. J Gastrointest Surg. 2009. PMID: 19165550

5

Gastric juice acidity in upper gastrointestinal diseases.

Lu PJ, Hsu PI, Chen CH, Hsiao M, Chang WC, Tseng HH, Lin KH, Chuah SK, Chen HC. Lu PJ, et al. Among authors: chuah sk. World J Gastroenterol. 2010 Nov 21;16(43):5496-501. doi: 10.3748/wjg.v16.i43.5496. World J Gastroenterol. 2010. PMID: 21086570 Free PMC article.

6

Randomized comparison of two nonbismuth-containing rescue therapies for Helicobacter pylori.

Hu TH, Chuah SK, Hsu PI, Wu DC, Tai WC, Chiu YC, Wu KL, Kuo CM, Hu ML. Hu TH, et al. Among authors: chuah sk. Am J Med Sci. 2011 Sep;342(3):177-81. doi: 10.1097/MAJ.0b013e31821fc2aa. Am J Med Sci. 2011. PMID: 21804375 Clinical Trial.

7

A new look at anti-Helicobacter pylori therapy.

Chuah SK, Tsay FW, Hsu PI, Wu DC. Chuah SK, et al. World J Gastroenterol. 2011 Sep 21;17(35):3971-5. doi: 10.3748/wjg.v17.i35.3971. World J Gastroenterol. 2011. PMID: 22046084 Free PMC article. Review.

8

Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori.

Chuah SK, Hsu PI, Chang KC, Chiu YC, Wu KL, Chou YP, Hu ML, Tai WC, Chiu KW, Chiou SS, Wu DC, Hu TH. Chuah SK, et al. Helicobacter. 2012 Jun;17(3):216-23. doi: 10.1111/j.1523-5378.2012.00937.x. Epub 2012 Mar 20. Helicobacter. 2012. PMID: 22515360 Clinical Trial.

9

2011 update on esophageal achalasia.

Chuah SK, Hsu PI, Wu KL, Wu DC, Tai WC, Changchien CS. Chuah SK, et al. World J Gastroenterol. 2012 Apr 14;18(14):1573-8. doi: 10.3748/wjg.v18.i14.1573. World J Gastroenterol. 2012. PMID: 22529685 Free PMC article. Review.

10

The efficacy of second-line anti-Helicobacter pylori therapy using an extended 14-day levofloxacin/amoxicillin/proton-pump inhibitor treatment--a pilot study.

Chuah SK, Tai WC, Hsu PI, Wu DC, Wu KL, Kuo CM, Chiu YC, Hu ML, Chou YP, Kuo YH, Liang CM, Chiu KW, Hu TH. Chuah SK, et al. Helicobacter. 2012 Oct;17(5):374-81. doi: 10.1111/j.1523-5378.2012.00960.x. Epub 2012 Jun 8. Helicobacter. 2012. PMID: 22967121 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

213 results

Search Page